New Options for Metastatic Breast Cancer

Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston.
Clinical journal of oncology nursing (Impact Factor: 0.91). 02/2009; 13(1):11-8. DOI: 10.1188/09.CJON.S1.11-18
Source: PubMed


Patients with advanced breast cancer are living longer and receiving multiple lines of chemotherapy; however, they eventually develop resistance to the agents. Two more agents have been approved for the treatment of breast cancer and will provide additional treatment options for such patients. Ixabepilone represents a new class of cytotoxic chemotherapy called the epothilones. Ixabepilone was approved for use as a single agent for the treatment of metastatic breast cancer resistant to taxanes, anthracyclines, and capecitabine, as well as in combination with capecitabine for disease refractory to taxanes and anthracyclines. Bevacizumab, a monoclonal antibody targeting vascular endothelial growth factor, was approved for first-line treatment of HER2-negative metastatic breast cancer in combination with paclitaxel. Understanding the efficacy, toxicity, and administration of the agents is crucial for oncology nurses to optimally educate and treat patients with advanced breast cancer.

5 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this study, we evaluated a high surface area fractional precipitation process to achieve the effective purification of paclitaxel, an anticancer agent, from plant cell cultures. Fractional precipitation experiments were performed by increasing the surface area per working volume (S/V) to 0.428/mm using a variety of ion exchange resins. When the cation exchange resin Amberlite IR 120 H was used, the highest purity (>85%) and yield (>80%) of paclitaxel could be obtained in the shortest fractional precipitation time (within 6 h). Use of an ion exchange resin resulted in the production of smaller paclitaxel precipitates since it inhibited the growth of particles. When Amberlite IR 120 H in particular was used, paclitaxel particles were 2 ∼ 3 times smaller (less than 30 μm radius) than those obtained in the absence of ion exchange resin. Paclitaxel particle size was inversely correlated with the zeta potential of the fractional precipitation solution after the addition of ion exchange resin.
    Biotechnology and Bioprocess Engineering 10/2012; 17(5). DOI:10.1007/s12257-012-0056-8 · 1.11 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Fractional precipitation is a simple, efficient method for pre-purifying paclitaxel extracted from plant cell cultures. However, the fractional precipitation process has been inherently problematic due to the lengthy precipitation time (∼3 days) that is required. An improved fractional precipitation process could significantly reduce the precipitation time by increasing the purity of crude extract and the surface area available for precipitation. Glass beads (7mm) were used to increase the surface area, and the optimal surface area per working volume (i.e. volume of reaction solution) (S/V) for achieving the highest purity and yield of paclitaxel possible was found to be 0.428mm−1. The content of paclitaxel dissolved in methanol that can be processed during fractional precipitation was evaluated, and it was established that up to 0.9% (w/v) pure paclitaxel content could be processed. This improved pre-purification process serves to minimize solvent usage and the size and complexity of the high performance liquid chromatography operation required for paclitaxel purification.
    PROCESS BIOCHEMISTRY 07/2009; 44(7):736-741. DOI:10.1016/j.procbio.2009.03.007 · 2.52 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A micelle-fractional precipitation hybrid process was developed for the effective pre-purification of the anticancer agent paclitaxel extracted from plant cell cultures. First, it was found that the efficiency of such a developed process could be remarkably enhanced by removing waxy substances originating from plant cells using the adsorbent sylopute. Paclitaxel yield was improved and the fractional precipitation time was shortened by increasing the surface area per working volume (S/V) of the reacting solution through the addition of a cation exchange resin (Amberlite IR120 or Amberlite 200), an anion exchange resin (Amberlite IRA400 or Amberlite IRA96), or glass beads. Most of the paclitaxel (>98%) could be obtained after about 12h of fractional precipitation using Amberlite 200. Purity increased with increasing fractional precipitation time up to 9h to about 85%, after which it showed little change. On the other hand, no paclitaxel precipitate was formed using either of the nonionic exchange resins because paclitaxel, which is hydrophobic, was strongly adsorbed on the hydrophobic resin surface. Since high-purity paclitaxel can be obtained in high yield and the precipitation time can be reduced by combining micelle formation with fractional precipitation, this hybrid method is expected to significantly enhance the final purification process.
    PROCESS BIOCHEMISTRY 08/2010; 45(8):1368-1374. DOI:10.1016/j.procbio.2010.05.010 · 2.52 Impact Factor
Show more


5 Reads
Available from